Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nivolumab and pembrolizumab | 1.36 | 0.2 | 5659 | 10 | 27 |
nivolumab | 0.32 | 0.7 | 6431 | 7 | 9 |
and | 1.11 | 0.5 | 7242 | 82 | 3 |
pembrolizumab | 1.06 | 0.1 | 4416 | 41 | 13 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nivolumab and pembrolizumab | 1.15 | 0.1 | 5051 | 50 |
nivolumab and pembrolizumab combination | 0.5 | 0.7 | 9703 | 69 |
nivolumab and pembrolizumab for melanoma | 0.64 | 0.5 | 3428 | 49 |
nivolumab and pembrolizumab side effects | 0.13 | 0.2 | 3104 | 66 |
nivolumab and pembrolizumab for mesothelioma | 0.84 | 0.2 | 4294 | 56 |
nivolumab and pembrolizumab for lung cancer | 0.45 | 0.7 | 432 | 10 |
pembrolizumab versus nivolumab for melanoma | 0.43 | 1 | 1095 | 58 |
pembrolizumab keytruda and nivolumab opdivo | 1.05 | 0.2 | 9979 | 98 |
pembrolizumab nivolumab difference | 0.71 | 0.5 | 96 | 24 |
nivolumab or pembrolizumab | 1.56 | 0.3 | 804 | 78 |
nivolumab vs pembrolizumab | 1.16 | 0.2 | 2648 | 26 |